Opposing roles of C/EBPα and eEF1A1 in Sp1-regulated miR-122 transcription

References

• Bandiera S, Pfeffer S, Baumert TF, et al. miR-122 – a key factor and therapeutic target in liver disease. J Hepatol. 2015;62:448–457.
   PubMed Web of Science ®Google Scholar
• Jopling CL, Yi M, Lancaster AM, et al. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science. 2005;309:1577–1581.
   PubMed Web of Science ®Google Scholar
• Esau C, Davis S, Murray SF, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006;3:87–98.
   PubMed Web of Science ®Google Scholar
• Castoldi M, Vujic Spasic M, Altamura S, et al. The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice. J Clin Invest. 2011;121:1386–1396.
   PubMed Web of Science ®Google Scholar
• Yang YM, Seo SY, Kim TH, et al. Decrease of microRNA-122 causes hepatic insulin resistance by inducing protein tyrosine phosphatase 1B, which is reversed by licorice flavonoid. Hepatology. 2012;56:2209–2220.
   PubMed Web of Science ®Google Scholar
• Li J, Ghazwani M, Zhang Y, et al. miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression. J Hepatol. 2013;58:522–528.
   PubMed Web of Science ®Google Scholar
• Zeng C, Wang YL, Xie C, et al. Identification of a novel TGF-beta-miR-122-fibronectin 1/serum response factor signaling cascade and its implication in hepatic fibrogenesis. Oncotarget. 2015;6:12224–12233.
   PubMedGoogle Scholar
• Bai S, Nasser MW, Wang B, et al. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J Biol Chem. 2009;284:32015–32027.
   PubMed Web of Science ®Google Scholar
• Tsai WC, Hsu PW, Lai TC, et al. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology. 2009;49:1571–1582.
   PubMed Web of Science ®Google Scholar
• Zeng C, Wang R, Li D, et al. A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma. Hepatology. 2010;52:1702–1712.
   Web of Science ®Google Scholar
• Tsai WC, Hsu SD, Hsu CS, et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest. 2012;122:2884–2897.
   PubMed Web of Science ®Google Scholar
• Hsu SH, Wang B, Kota J, et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest. 2012;122:2871–2883.
   PubMed Web of Science ®Google Scholar
• Lourenço AR, Coffer PJ. A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood. Oncogene. 2017;36:5221–5230.
   PubMed Web of Science ®Google Scholar
• Zhang S, Jiang T, Feng L, et al. Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha. J Mol Med. 2012;90:1069–1077.
   PubMed Web of Science ®Google Scholar
• Reebye V, Sætrom P, Mintz PJ, et al. Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo. Hepatology. 2014;59:216–227.
   PubMed Web of Science ®Google Scholar
• Xu H, He JH, Xiao ZD, et al. Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development. Hepatology. 2010;52:1431–1442.
   PubMed Web of Science ®Google Scholar
• Laudadio I, Manfroid I, Achouri Y, et al. A feedback loop between the liver-enriched transcription factor network and miR-122 controls hepatocyte differentiation. Gastroenterology. 2012;142:119–129.
   PubMed Web of Science ®Google Scholar
• Song K, Han C, Zhang J, et al. Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells. Hepatology. 2013;58:1681–1692.
   PubMed Web of Science ®Google Scholar
• He J, Zhao K, Zheng L, et al. Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells. Mol Cancer. 2015;14:163.
   PubMed Web of Science ®Google Scholar
• Beishline K, Azizkhan-Clifford J. Sp1 and the ‘hallmarks of cancer’. Febs J. 2015;282:224–258.
   PubMed Web of Science ®Google Scholar
• Abbas W, Kumar A, Herbein G. The eEF1A proteins: at the crossroads of oncogenesis, apoptosis, and viral infections. Front Oncol. 2015;5:75.
   PubMed Web of Science ®Google Scholar
• Grassi G, Scaggiante B, Farra R, et al. The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade. Biochimie. 2007;89:1544–1552.
   PubMed Web of Science ®Google Scholar
• Dong J, Tsai-Morris CH, Dufau ML. A novel estradiol/estrogen receptor alpha-dependent transcriptional mechanism controls expression of the human prolactin receptor. J Biol Chem. 2006;281:18825–18836.
   PubMed Web of Science ®Google Scholar
• Hein N, Jiang K, Cornelissen C, et al. TGFbeta1 enhances MAD1 expression and stimulates promoter-bound Pol II phosphorylation: basic functions of C/EBP, SP and SMAD3 transcription factors. BMC Mol Biol. 2011;12:9.
   PubMed Web of Science ®Google Scholar
• Lamberti A, Longo O, Marra M, et al. C-Raf antagonizes apoptosis induced by IFN-alpha in human lung cancer cells by phosphorylation and increase of the intracellular content of elongation factor 1A. Cell Death Differ. 2007;14:952–962.
   PubMed Web of Science ®Google Scholar
• Pecorari L, Marin O, Silvestri C, et al. Elongation factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility. Mol Cancer. 2009;8:58.
   PubMed Web of Science ®Google Scholar
• Choi WI, Kim Y, Yu MY, et al. Eukaryotic translation initiator protein 1A isoform, CCS-3, enhances the transcriptional repression of p21CIP1 by proto-oncogene FBI-1 (Pokemon/ZBTB7A). Cell Physiol Biochem. 2009;23:359–370.
   PubMedGoogle Scholar
• Sandelin A, Carninci P, Lenhard B, et al. Mammalian RNA polymerase II core promoters: insights from genome-wide studies. Nat Rev Genet. 2007;8:424–436.
   PubMed Web of Science ®Google Scholar
• Nordhoff E, Krogsdam AM, Jorgensen HF, et al. Rapid identification of DNA-binding proteins by mass spectrometry. Nat Biotechnol. 1999;17:884–888.
   PubMed Web of Science ®Google Scholar